Rodriguez Estelamari相关文献与解析，生知库

Evolving trends in lung cancer risk factors in the ten most populous countries: an analysis of data from the 2019 Global Burden of Disease Study

十大人口最多国家肺癌风险因素的演变趋势：基于2019年全球疾病负担研究数据的分析

doi:10.1016/j.eclinm.2024.103033

Jani, Chinmay T; Kareff, Samuel A; Morgenstern-Kaplan, Dan; Salazar, Ana S; Hanbury, Georgina; Salciccioli, Justin D; Marshall, Dominic C; Shalhoub, Joseph; Singh, Harpreet; Rodriguez, Estelamari; Lopes, Gilberto

Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.

不同MET肿瘤改变对I型和II型MET抑制剂的反应性

期刊:Clinical and Translational Medicine

影响因子:6.8

doi:10.1002/ctm2.70338

Murciano-Goroff Yonina R, Foglizzo Valentina, Chang Jason, Rekhtman Natasha, Sisk Ann Elizabeth, Gibson Jamie, Judka Lia, Clemens Kristen, Roa Paola, Ahmed Shaza Sayed, Bremer Nicole V, Binaco Courtney Lynn, Muzungu Sherifah Kemigisha, Rodriguez Estelamari, Merrill Madeline, Sgroe Erica, Repetto Matteo, Stadler Zsofia K, Berger Michael F, Yu Helena A, Toska Eneda, Kannan Srinivasaraghavan, Verma Chandra S, Drilon Alexander, Cocco Emiliano

Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population

对以西班牙裔/拉丁裔为主的非小细胞肺癌患者通过ctDNA检测到的偶然致病性种系发现进行表征

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers16061150

Vallabhaneni, Esha; Kareff, Samuel A; Barnett, Reagan M; Drusbosky, Leylah M; Dalal, Shivani; Raez, Luis E; Santos, Edgardo S; Albrecht, Federico; Cusnir, Mike; Rodriguez, Estelamari

The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors

实体瘤中HRAS突变的基因组学、转录组学和免疫学特征

期刊:Cancers

影响因子:4.4

doi:10.3390/cancers16081572

Kareff, Samuel A; Trabolsi, Asaad; Krause, Harris B; Samec, Timothy; Elliott, Andrew; Rodriguez, Estelamari; Olazagasti, Coral; Watson, Dionysios C; Bustos, Matias A; Hoon, Dave S B; Graff, Stephanie L; Antonarakis, Emmanuel S; Goel, Sanjay; Sledge, George; Lopes, Gilberto

Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors

TROP2 (TACSTD2) 表达在实体瘤中的基因组学、免疫学和预后关联

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyae168

Morgenstern-Kaplan, Dan; Kareff, Samuel A; Trabolsi, Asaad; Rodriguez, Estelamari; Krause, Harris; Ribeiro, Jennifer R; Tan, Heng; Antonarakis, Emmanuel S; Lou, Emil; Nagasaka, Misako; Algaze, Sandra; Lenz, Heinz-Josef; Liu, Stephen V; Halmos, Balazs; Hoon, Dave S B; Seeber, Andreas; Ma, Patrick C; El-Deiry, Wafik S; Vanderwalde, Ari M; Lopes, Gilberto

免疫/内分泌

发表日期：2024

文献求助收藏

Rethinking how mobile units can catalyze progress on lung cancer screening: a scoping review of what we have learned

重新思考移动单元如何促进肺癌筛查进展：我们已了解情况的范围界定综述

期刊:Journal of Thoracic Disease

影响因子:1.9

doi:10.21037/jtd-24-846

Karanth, Shama D; Divaker, Joel; Blair, Marissa; Gray, Jhanelle E; Hochhegger, Bruno; Kobetz, Erin; Machuca, Tiago; Rackauskas, Mindaugas; Yang, Danting; Rodriguez, Estelamari; Schabath, Matthew B; Yoon, Hyung-Suk; Braithwaite, Dejana

Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell Carcinomas

TTF-1抗体8G7G3/1和SPT24的免疫反应模式表明，大多数肺小细胞癌和非肺小细胞癌具有不同的免疫表型。

期刊:International Journal of Surgical Pathology

影响因子:1

doi:10.1177/10668969231171940

Briski, Laurence M; Aron, Manju; Epstein, Jonathan I; Russell, Daniel H; Assarzadegan, Naziheh; Delma, Katiana S; O'Dell, Henry; Rodriguez, Estelamari; Montgomery, Elizabeth A; Kryvenko, Oleksandr N

Disparities in Utilization of Immune Checkpoint Inhibitor Therapy Among Older Patients With Advanced Non-Small Cell Lung Cancer: A SEER-Medicare Analysis

老年晚期非小细胞肺癌患者免疫检查点抑制剂治疗利用率差异：一项基于SEER-Medicare数据库的分析

期刊:

影响因子:

doi:10.1200/OA.24.00008

Yang, Danting; Karanth, Shama D; Yoon, Hyung-Suk; Yang, Jae Jeong; Lou, Xiwei; Bian, Jiang; Zhang, Dongyu; Guo, Yi; Yaghjyan, Lusine; Akinyemiju, Tomi; Rodriguez, Estelamari; Mehta, Hiren J; Braithwaite, Dejana

Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma

美国可手术恶性胸膜间皮瘤患者的生存率差异，是由健康社会决定因素和治疗机会不足造成的

期刊:Jama Network Open

影响因子:9.7

doi:10.1001/jamanetworkopen.2023.4261

Alnajar, Ahmed; Kareff, Samuel A; Razi, Syed S; Rao, J Sunil; De Lima Lopes, Gilberto; Nguyen, Dao M; Villamizar, Nestor; Rodriguez, Estelamari

发表日期：2023

文献求助收藏

USPSTF Lung Cancer Screening Guidelines and Disparities in Screening Adherence

美国预防服务工作组肺癌筛查指南及筛查依从性差异

Evolving trends in lung cancer risk factors in the ten most populous countries: an analysis of data from the 2019 Global Burden of Disease Study

十大人口最多国家肺癌风险因素的演变趋势：基于2019年全球疾病负担研究数据的分析

Responsiveness of different MET tumour alterations to type I and type II MET inhibitors.

不同MET肿瘤改变对I型和II型MET抑制剂的反应性

Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population

对以西班牙裔/拉丁裔为主的非小细胞肺癌患者通过ctDNA检测到的偶然致病性种系发现进行表征

The Genomic, Transcriptomic, and Immunologic Landscape of HRAS Mutations in Solid Tumors

实体瘤中HRAS突变的基因组学、转录组学和免疫学特征

Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors

TROP2 (TACSTD2) 表达在实体瘤中的基因组学、免疫学和预后关联

Rethinking how mobile units can catalyze progress on lung cancer screening: a scoping review of what we have learned

重新思考移动单元如何促进肺癌筛查进展：我们已了解情况的范围界定综述

Patterns of Immunoreactivity with TTF-1 Antibodies 8G7G3/1 and SPT24 Suggest Distinct Immunoprofiles Between Most Pulmonary and Nonpulmonary Small Cell Carcinomas

TTF-1抗体8G7G3/1和SPT24的免疫反应模式表明，大多数肺小细胞癌和非肺小细胞癌具有不同的免疫表型。

Disparities in Utilization of Immune Checkpoint Inhibitor Therapy Among Older Patients With Advanced Non-Small Cell Lung Cancer: A SEER-Medicare Analysis

老年晚期非小细胞肺癌患者免疫检查点抑制剂治疗利用率差异：一项基于SEER-Medicare数据库的分析

Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma

美国可手术恶性胸膜间皮瘤患者的生存率差异，是由健康社会决定因素和治疗机会不足造成的